
Albert T. Chou
Examiner (ID: 16812, Phone: (571)272-6045 , Office: P/2471 )
| Most Active Art Unit | 2471 |
| Art Unit(s) | 2471, 2416, 2662, 2616 |
| Total Applications | 817 |
| Issued Applications | 681 |
| Pending Applications | 12 |
| Abandoned Applications | 125 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11090702
[patent_doc_number] => 20160287670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'METHODS OF USE FOR IL-22 IN THE TREATMENT OF GASTROINTESTINAL GRAFT VS. HOST DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/035055
[patent_app_country] => US
[patent_app_date] => 2014-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 59
[patent_figures_cnt] => 59
[patent_no_of_words] => 25187
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035055
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/035055 | METHODS OF USE FOR IL-22 IN THE TREATMENT OF GASTROINTESTINAL GRAFT VS. HOST DISEASE | Nov 6, 2014 | Abandoned |
Array
(
[id] => 10240463
[patent_doc_number] => 20150125458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'Anti-CCL17 Antibodies'
[patent_app_type] => utility
[patent_app_number] => 14/534525
[patent_app_country] => US
[patent_app_date] => 2014-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17727
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14534525
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/534525 | Anti-CCL17 antibodies | Nov 5, 2014 | Issued |
Array
(
[id] => 10279994
[patent_doc_number] => 20150164991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'Method and Kit for Evaluating and Monitoring a Treatment Program for Anemia'
[patent_app_type] => utility
[patent_app_number] => 14/531999
[patent_app_country] => US
[patent_app_date] => 2014-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13733
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14531999
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/531999 | Method and Kit for Evaluating and Monitoring a Treatment Program for Anemia | Nov 2, 2014 | Abandoned |
Array
(
[id] => 10281670
[patent_doc_number] => 20150166667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/521494
[patent_app_country] => US
[patent_app_date] => 2014-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 15172
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14521494
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/521494 | METHODS AND COMPOSITIONS FOR TREATING CANCER | Oct 22, 2014 | Abandoned |
Array
(
[id] => 10761947
[patent_doc_number] => 20160108100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'Interference Peptides and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/518632
[patent_app_country] => US
[patent_app_date] => 2014-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 26522
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14518632
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/518632 | Interference peptides and use thereof | Oct 19, 2014 | Issued |
Array
(
[id] => 10262336
[patent_doc_number] => 20150147333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'ANTI-RSPO ANTIBODIES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/517709
[patent_app_country] => US
[patent_app_date] => 2014-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 56643
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14517709
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/517709 | ANTI-RSPO ANTIBODIES AND METHODS OF USE | Oct 16, 2014 | Abandoned |
Array
(
[id] => 9838530
[patent_doc_number] => 20150030611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'Monitoring and Modulating HGF/HGFR Activity'
[patent_app_type] => utility
[patent_app_number] => 14/508576
[patent_app_country] => US
[patent_app_date] => 2014-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19979
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14508576
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/508576 | Monitoring and Modulating HGF/HGFR Activity | Oct 6, 2014 | Abandoned |
Array
(
[id] => 13761165
[patent_doc_number] => 10172911
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => Methods of modulating erythropoiesis with arginine vasopressin receptor 1B molecules
[patent_app_type] => utility
[patent_app_number] => 15/022531
[patent_app_country] => US
[patent_app_date] => 2014-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 65
[patent_no_of_words] => 25528
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15022531
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/022531 | Methods of modulating erythropoiesis with arginine vasopressin receptor 1B molecules | Sep 30, 2014 | Issued |
Array
(
[id] => 11018081
[patent_doc_number] => 20160215033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'Granulocyte Macrophage Colony-Stimulating Factor Compositions'
[patent_app_type] => utility
[patent_app_number] => 14/916027
[patent_app_country] => US
[patent_app_date] => 2014-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 14251
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14916027
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/916027 | Granulocyte Macrophage Colony-Stimulating Factor Compositions | Sep 2, 2014 | Abandoned |
Array
(
[id] => 11003843
[patent_doc_number] => 20160200792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'Purification Process for PTH'
[patent_app_type] => utility
[patent_app_number] => 14/912984
[patent_app_country] => US
[patent_app_date] => 2014-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3832
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14912984
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/912984 | Purification Process for PTH | Aug 20, 2014 | Abandoned |
Array
(
[id] => 9806805
[patent_doc_number] => 20150018750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'Cosmetic Agent or Skin Regeneration Promoter Comprising a Culture Sup of Non-human Stem Cells, and a Method for Introducing a Protein'
[patent_app_type] => utility
[patent_app_number] => 14/455557
[patent_app_country] => US
[patent_app_date] => 2014-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11650
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14455557
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/455557 | Cosmetic Agent or Skin Regeneration Promoter Comprising a Culture Sup of Non-human Stem Cells, and a Method for Introducing a Protein | Aug 7, 2014 | Abandoned |
Array
(
[id] => 10822088
[patent_doc_number] => 20160168252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'ANTIBODIES, COMPOUNDS AND DERIVATIVES THEREOF FOR USE IN THE TREATMENT OF MALE INFERTILITY'
[patent_app_type] => utility
[patent_app_number] => 14/909701
[patent_app_country] => US
[patent_app_date] => 2014-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15404
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14909701
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/909701 | Antibodies, compounds and derivatives thereof for use in the treatment of male infertility | Aug 3, 2014 | Issued |
Array
(
[id] => 10978460
[patent_doc_number] => 20160175401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'COMPOITIONS AND METHODS FOR MODULATING THERMOGENESIS USING PTH-RELATED AND EGF-RELATED COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/909163
[patent_app_country] => US
[patent_app_date] => 2014-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 59509
[patent_no_of_claims] => 92
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14909163
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/909163 | COMPOITIONS AND METHODS FOR MODULATING THERMOGENESIS USING PTH-RELATED AND EGF-RELATED COMPOUNDS | Jul 29, 2014 | Abandoned |
Array
(
[id] => 10313613
[patent_doc_number] => 20150198616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'METHODS OF DIAGNOSING AND DETERMINING RISK OF DEVELOPING DISSEMINATED INTRAVASCULAR COAGULATION'
[patent_app_type] => utility
[patent_app_number] => 14/323793
[patent_app_country] => US
[patent_app_date] => 2014-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20725
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323793
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/323793 | METHODS OF DIAGNOSING AND DETERMINING RISK OF DEVELOPING DISSEMINATED INTRAVASCULAR COAGULATION | Jul 2, 2014 | Abandoned |
Array
(
[id] => 9858396
[patent_doc_number] => 20150038413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/309496
[patent_app_country] => US
[patent_app_date] => 2014-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 44659
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14309496
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/309496 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME | Jun 18, 2014 | Pending |
Array
(
[id] => 10954824
[patent_doc_number] => 20140357846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'THYROID STIMULATING HORMONE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/308284
[patent_app_country] => US
[patent_app_date] => 2014-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 14723
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14308284
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/308284 | THYROID STIMULATING HORMONE COMPOSITIONS | Jun 17, 2014 | Abandoned |
Array
(
[id] => 17843791
[patent_doc_number] => 11433134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-06
[patent_title] => Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration
[patent_app_type] => utility
[patent_app_number] => 14/305450
[patent_app_country] => US
[patent_app_date] => 2014-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 20931
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14305450
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/305450 | Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration | Jun 15, 2014 | Issued |
Array
(
[id] => 11114902
[patent_doc_number] => 20160311875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'NEW PEPTIDE AND APPLICATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/893730
[patent_app_country] => US
[patent_app_date] => 2014-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14738
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14893730
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/893730 | Peptide and application thereof | May 22, 2014 | Issued |
Array
(
[id] => 11642425
[patent_doc_number] => 09663778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => 'Long-acting coagulation factors and methods of producing same'
[patent_app_type] => utility
[patent_app_number] => 14/274061
[patent_app_country] => US
[patent_app_date] => 2014-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 101
[patent_figures_cnt] => 190
[patent_no_of_words] => 78241
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14274061
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/274061 | Long-acting coagulation factors and methods of producing same | May 8, 2014 | Issued |
Array
(
[id] => 9686500
[patent_doc_number] => 20140243265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'ANTIBODIES TO MODIFIED HUMAN IGF-1/E PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/271687
[patent_app_country] => US
[patent_app_date] => 2014-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8602
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14271687
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/271687 | ANTIBODIES TO MODIFIED HUMAN IGF-1/E PEPTIDES | May 6, 2014 | Abandoned |